Source link : https://newshealth.biz/health-news/glp-1-promising-option-to-counter-antipsychotic-weight-gain/
Semaglutide is linked to significant weight loss and glucose levels in adults with schizophrenia, overweight/obesity, and prediabetes compared with placebo, new research shows. Medscape Medical News Source link : https://www.medscape.com/viewarticle/glp-1-promising-option-offset-antipsychotic-weight-gain-2025a1000ob7?src=rss Author : Publish date : 2025-09-15 12:01:00 Copyright for syndicated content belongs to the linked Source.
The post GLP-1: Promising Option to Counter Antipsychotic Weight Gain first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-15 12:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8